Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Plekhg4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Plekhg4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLEKHG4 mRNA | CTD | PMID:21570461 | Plekhg4 | Rat | 2-palmitoylglycerol | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of PLEKHG4 mRNA | CTD | PMID:37199045 | Plekhg4 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Plekhg4 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of PLEKHG4 mRNA | CTD | PMID:25172293 | Plekhg4 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Plekhg4 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Plekhg4 (Mus musculus) | 6480464 | bisphenol S affects the methylation of PLEKHG4 gene | CTD | PMID:31683443 | Plekhg4 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Decitabine affects the expression of PLEKHG4 mRNA | CTD | PMID:23300844 | Plekhg4 | Rat | acrolein | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | Plekhg4 | Rat | aflatoxin B1 | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of PLEKHG4 mRNA | CTD | PMID:22100608|PMID:32234424 | Plekhg4 | Rat | aldehydo-D-glucose | increases expression | ISO | Plekhg4 (Mus musculus) | 6480464 | Glucose results in increased expression of PLEKHG4 mRNA | CTD | PMID:39922521 | Plekhg4 | Rat | all-trans-retinoic acid | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of PLEKHG4 mRNA | CTD | PMID:33167477 | Plekhg4 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Plekhg4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PLEKHG4 mRNA | CTD | PMID:36189433 | Plekhg4 | Rat | alpha-pinene | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | Plekhg4 | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of PLEKHG4 mRNA | CTD | PMID:35163327 | Plekhg4 | Rat | amiodarone | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of PLEKHG4 mRNA | CTD | PMID:19774075 | Plekhg4 | Rat | aristolochic acid A | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of PLEKHG4 protein | CTD | PMID:33212167 | Plekhg4 | Rat | atrazine | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of PLEKHG4 mRNA | CTD | PMID:22378314 | Plekhg4 | Rat | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of PLEKHG4 mRNA | CTD | PMID:36841081 | Plekhg4 | Rat | benzo[a]pyrene | increases methylation | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of PLEKHG4 3' UTR; Benzo(a)pyrene results in increased methylation of more ... | CTD | PMID:27901495 | Plekhg4 | Rat | benzo[a]pyrene | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of PLEKHG4 mRNA | CTD | PMID:32234424 | Plekhg4 | Rat | benzo[a]pyrene | affects methylation | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of PLEKHG4 exon | CTD | PMID:27901495 | Plekhg4 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of PLEKHG4 mRNA | CTD | PMID:31163220 | Plekhg4 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PLEKHG4 mRNA | CTD | PMID:25181051 | Plekhg4 | Rat | bisphenol A | increases expression | ISO | Plekhg4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PLEKHG4 mRNA | CTD | PMID:29165653 | Plekhg4 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of PLEKHG4 gene | CTD | PMID:28505145 | Plekhg4 | Rat | bisphenol A | decreases methylation | ISO | Plekhg4 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of PLEKHG4 promoter | CTD | PMID:27312807 | Plekhg4 | Rat | bisphenol A | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Plekhg4 | Rat | cisplatin | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of PLEKHG4 mRNA | CTD | PMID:27594783 | Plekhg4 | Rat | cisplatin | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of PLEKHG4 mRNA | CTD | PMID:27392435 | Plekhg4 | Rat | cisplatin | affects expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Cisplatin affects the expression of PLEKHG4 mRNA | CTD | PMID:23300844 | Plekhg4 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of PLEKHG4 mRNA | CTD | PMID:26033743 | Plekhg4 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of PLEKHG4 mRNA | CTD | PMID:26033743 | Plekhg4 | Rat | coumarin | increases phosphorylation | ISO | PLEKHG4 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of PLEKHG4 protein | CTD | PMID:35688186 | Plekhg4 | Rat | D-glucose | increases expression | ISO | Plekhg4 (Mus musculus) | 6480464 | Glucose results in increased expression of PLEKHG4 mRNA | CTD | PMID:39922521 | Plekhg4 | Rat | dexamethasone | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Plekhg4 | Rat | dimethylarsinic acid | multiple interactions | ISO | Plekhg4 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Plekhg4 | Rat | dorsomorphin | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Plekhg4 | Rat | entinostat | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | entinostat results in increased expression of PLEKHG4 mRNA | CTD | PMID:27188386 | Plekhg4 | Rat | folic acid | decreases expression | ISO | Plekhg4 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PLEKHG4 mRNA | CTD | PMID:25629700 | Plekhg4 | Rat | gallic acid | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Gallic Acid results in increased expression of PLEKHG4 mRNA | CTD | PMID:34408198 | Plekhg4 | Rat | glucose | increases expression | ISO | Plekhg4 (Mus musculus) | 6480464 | Glucose results in increased expression of PLEKHG4 mRNA | CTD | PMID:39922521 | Plekhg4 | Rat | GSK-J4 | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | GSK-J4 results in decreased expression of PLEKHG4 mRNA | CTD | PMID:29301935 | Plekhg4 | Rat | indometacin | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Plekhg4 | Rat | methylarsonic acid | multiple interactions | ISO | Plekhg4 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Plekhg4 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Plekhg4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PLEKHG4 mRNA | CTD | PMID:36189433 | Plekhg4 | Rat | Muconic dialdehyde | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | muconaldehyde results in decreased expression of PLEKHG4 mRNA | CTD | PMID:40300100 | Plekhg4 | Rat | niclosamide | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of PLEKHG4 mRNA | CTD | PMID:36318118 | Plekhg4 | Rat | O-methyleugenol | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of PLEKHG4 mRNA | CTD | PMID:32234424 | Plekhg4 | Rat | okadaic acid | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of PLEKHG4 mRNA | CTD | PMID:38832940 | Plekhg4 | Rat | ozone | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | Plekhg4 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PLEKHG4 mRNA | CTD | PMID:33387578 | Plekhg4 | Rat | phenylmercury acetate | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Plekhg4 | Rat | pirinixic acid | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Plekhg4 | Rat | potassium chromate | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of PLEKHG4 mRNA | CTD | PMID:22714537 | Plekhg4 | Rat | quercetin | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Quercetin results in increased expression of PLEKHG4 mRNA | CTD | PMID:21632981 | Plekhg4 | Rat | rotenone | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of PLEKHG4 mRNA | CTD | PMID:32178731 | Plekhg4 | Rat | SB 431542 | multiple interactions | ISO | PLEKHG4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Plekhg4 | Rat | silicon dioxide | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of PLEKHG4 mRNA | CTD | PMID:25895662 | Plekhg4 | Rat | sodium arsenate | multiple interactions | ISO | Plekhg4 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Plekhg4 | Rat | sodium arsenite | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of PLEKHG4 mRNA | CTD | PMID:38568856|PMID:39719251 | Plekhg4 | Rat | sodium arsenite | multiple interactions | ISO | Plekhg4 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Plekhg4 | Rat | sodium arsenite | decreases expression | ISO | Plekhg4 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PLEKHG4 mRNA | CTD | PMID:37682722 | Plekhg4 | Rat | temozolomide | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of PLEKHG4 mRNA | CTD | PMID:31758290 | Plekhg4 | Rat | thimerosal | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of PLEKHG4 mRNA | CTD | PMID:27188386 | Plekhg4 | Rat | titanium dioxide | increases methylation | ISO | Plekhg4 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of PLEKHG4 promoter | CTD | PMID:35295148 | Plekhg4 | Rat | trimellitic anhydride | increases expression | ISO | Plekhg4 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of PLEKHG4 mRNA | CTD | PMID:19042947 | Plekhg4 | Rat | tunicamycin | increases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of PLEKHG4 mRNA | CTD | PMID:29453283 | Plekhg4 | Rat | urethane | decreases expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Urethane results in decreased expression of PLEKHG4 mRNA | CTD | PMID:28818685 | Plekhg4 | Rat | valproic acid | increases methylation | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of PLEKHG4 gene | CTD | PMID:29154799 | Plekhg4 | Rat | valproic acid | affects expression | ISO | PLEKHG4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PLEKHG4 mRNA | CTD | PMID:25979313 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















